Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Johnson

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
European Child & Adolescent Psychiatry|March 9, 2006
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorderPhilip Hazell, Shuyu Zhang, Tomasz Wolańczyk, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 23, 2022
Neurodevelopmental disorders and somatic diagnoses in a national cohort of children born before 24 weeks of gestationEva Morsing, Pia Lundgren, Anna-Lena Hård, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 21, 2014
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study designDavid R Coghill, Tobias Banaschewski, Michel Lecendreux, et al.
Acta Paediatrica (Oslo, Norway : 1992)|April 8, 2022
National cohort of infants born before 24 gestational weeks showed increased survival rates but no improvement in neonatal morbidityPia Lundgren, Eva Morsing, Anna-Lena Hård, et al.
BMC Psychiatry|August 6, 2022
Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten childrenParisa Hajjari, Malin Huldt Oldmark, Elisabeth Fernell, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 13, 2016
Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy studyJeffrey H Newcorn, Valerie Harpin, Michael Huss, et al.
Journal of Clinical and Experimental Neuropsychology|January 21, 2026
Trade-off between speed and accuracy: associations between obsessive-compulsive symptoms and meticulousness in PANSHelena Holmäng, Rosanna Fagerudd, Parisa Hajjari, et al.
Brain Communications|July 22, 2022
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 yearsJoel Simrén, Ulf Andreasson, Johan Gobom, et al.
Neurology|October 11, 2022
Reader Response: Lack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children StudyRajat Gupta, Dritan Agalliu, Alberto Spalice, et al.
European Child & Adolescent Psychiatry|February 1, 2006
A comparison of North American versus non-North American ADHD study populationsJan K Buitelaar, Joanne Barton, Marina Danckaerts, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
European Child & Adolescent Psychiatry|March 9, 2006
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorderPhilip Hazell, Shuyu Zhang, Tomasz Wolańczyk, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 23, 2022
Neurodevelopmental disorders and somatic diagnoses in a national cohort of children born before 24 weeks of gestationEva Morsing, Pia Lundgren, Anna-Lena Hård, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 21, 2014
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study designDavid R Coghill, Tobias Banaschewski, Michel Lecendreux, et al.
Acta Paediatrica (Oslo, Norway : 1992)|April 8, 2022
National cohort of infants born before 24 gestational weeks showed increased survival rates but no improvement in neonatal morbidityPia Lundgren, Eva Morsing, Anna-Lena Hård, et al.
BMC Psychiatry|August 6, 2022
Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten childrenParisa Hajjari, Malin Huldt Oldmark, Elisabeth Fernell, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 13, 2016
Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy studyJeffrey H Newcorn, Valerie Harpin, Michael Huss, et al.
Journal of Clinical and Experimental Neuropsychology|January 21, 2026
Trade-off between speed and accuracy: associations between obsessive-compulsive symptoms and meticulousness in PANSHelena Holmäng, Rosanna Fagerudd, Parisa Hajjari, et al.
Brain Communications|July 22, 2022
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 yearsJoel Simrén, Ulf Andreasson, Johan Gobom, et al.
Neurology|October 11, 2022
Reader Response: Lack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children StudyRajat Gupta, Dritan Agalliu, Alberto Spalice, et al.
European Child & Adolescent Psychiatry|February 1, 2006
A comparison of North American versus non-North American ADHD study populationsJan K Buitelaar, Joanne Barton, Marina Danckaerts, et al.
Pageof 6